Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Marjorie M, Luckey"'
Publikováno v:
Journal of Bone and Mineral Research. 29:1745-1755
Despite wide variations in hip rates fractures worldwide, reasons for such differences are not clear. Furthermore, secular trends in the age-specific hip fracture rates are changing the world map of this devastating disease, with the highest rise pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6d881684dfcb46d9611f53ebb99e41c
https://doi.org/10.1002/jbmr.2218
https://doi.org/10.1002/jbmr.2218
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 28(5)
We investigated the prevalence and incidence of vertebral fractures worldwide. We used a systematic Medline search current to 2015 and updated as per authors’ libraries. A total of 62 articles of fair to good quality and comparable methods for vert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eb3d2ac0fbb7d430c926fb5e15f4b43
https://pubmed.ncbi.nlm.nih.gov/28168409
https://pubmed.ncbi.nlm.nih.gov/28168409
Autor:
Nelson B. Watts, John P. Bilezikian, Pauline M. Camacho, Susan L. Greenspan, Steven T. Harris, Stephen F. Hodgson, Michael Kleerekoper, Marjorie M. Luckey, Michael R. McClung, Rachel Pessah Pollack, Steven M. Petak, Donald A. Bergman, Neil Binkley, Paul D. Miller
Publikováno v:
Endocrine Practice. 16:1-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9281afd9bcba26fcb88571ca95f5199
https://doi.org/10.4158/ep.16.s3.1
https://doi.org/10.4158/ep.16.s3.1
Autor:
Kenneth G. Saag, Paul D. Miller, Steven Boonen, Nelson B. Watts, Jonathan D. Adachi, John P. Bilezikian, Ego Seeman, Robert Lindsay, Susan L. Greenspan, Pierre D. Delmas, Thomas Lang, Suzanne Meeves, Marjorie M. Luckey
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 93:3785-3793
Anabolic responsiveness to teriparatide can be blunted or delayed in patients previously treated with alendronate. The extent of this effect is different for other antiresorptives. This study evaluated the early anabolic effects of teriparatide in po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::813478f7ddbcb32284181c4a0310a6ba
https://doi.org/10.1210/jc.2008-0353
https://doi.org/10.1210/jc.2008-0353
Autor:
Paul D. Miller, John P. Bilezikian, E. Michael Lewiecki, Michael Maricic, Marjorie M. Luckey, Marc C. Hochberg, Cyrus Cooper
Publikováno v:
Journal of Clinical Densitometry. 11:313-324
The Eighth Annual Santa Fe Bone Symposium convened August 3-4, 2007, in Santa Fe, New Mexico, USA, immediately preceded by the Research Symposium in Metabolic Bone Disease and Osteoporosis Update for Endocrine Fellows, and followed by the Internation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35dc7a9920b2ad67fa53dc98fec67130
https://doi.org/10.1016/j.jocd.2007.12.017
https://doi.org/10.1016/j.jocd.2007.12.017
Autor:
E. Michael Lewiecki, Marjorie M. Luckey, Sanford Baim, Brian C. Lentle, Robert W. Downs, Charles R. Wilson
Publikováno v:
Journal of Clinical Densitometry. 8:371-378
Measurement of bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA) is used to diagnose osteoporosis, assess the risk of fracture, and monitor changes in BMD over time. Because biological changes in BMD are usually small in proportion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2074c126df7665c4b93ab93d1953b92c
https://doi.org/10.1385/jcd:8:4:371
https://doi.org/10.1385/jcd:8:4:371
Autor:
Marsha Zion, Lillian Woelfert, Felicia Cosman, Robert S. Lindsay, Jeri W. Nieves, Marjorie M. Luckey
Publikováno v:
New England Journal of Medicine. 353:566-575
Parathyroid hormone (PTH), unlike antiresorptive agents, which lessen bone remodeling, initially stimulates bone formation and later promotes remodeling. Recent findings pose a question of efficacy when administering PTHwith alendronate whether or no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81cc1041a08302335928134f6f3ad8f8
https://doi.org/10.1056/nejmoa050157
https://doi.org/10.1056/nejmoa050157
Autor:
B. Bonvoisin, Pierre D. Delmas, David L. Kendler, N. Mairon, Robert R. Recker, M. A. Bolognese, Dieter Felsenberg, Michael R. McClung, J. A. Stakkestad, Paul D. Miller, Jean-Yves Reginster, Cyrus Cooper, Marjorie M. Luckey, Liviu Macovei, E. Michael Lewiecki, C. Hughes
Publikováno v:
Journal of Bone and Mineral Research. 20:1315-1322
Once-monthly (50/50, 100, and 150 mg) and daily (2.5 mg; 3-year vertebral fracture risk reduction: 52%) oral ibandronate regimens were compared in 1609 women with postmenopausal osteoporosis. At least equivalent efficacy and similar safety and tolera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ab7977a0745adeaa1a78e340f0becf8
https://doi.org/10.1359/jbmr.050313
https://doi.org/10.1359/jbmr.050313
Autor:
Donald A. Bergman, Howard R. Nankin, John P. Bilezikian, C. Conrad Johnston, Robert J. Anderson, Robert R. Recker, Michael Kleerekoper, Herbert I. Rettinger, Richard A. Dickey, Anne L. Peters, Steven M. Petak, Bart L. Clarke, Stephen F. Hodgson, Helena W. Rodbard, T. Kenney Gray, Nelson B. Watts, Pasquale Palumbo, Zachary T. Bloomgarden, Marjorie M. Luckey, Michael R. McClung, Robert Lindsay, Harvey A. Rubenstein, David W. Harris
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd8a00816696fc02127839b865615413
https://doi.org/10.4158/ep.9.6.544
https://doi.org/10.4158/ep.9.6.544
Autor:
Henry G. Bone, Tobias J. de Villiers, Nigel Gilchrist, Mei X. Wu, Daifotis Anastasia G, John J. Orloff, Arthur C. Santora, Marjorie M Luckey, Michael W Davie
Publikováno v:
Obstetrics & Gynecology. 101:711-721
To evaluate the efficacy and safety of alendronate 35 mg once weekly compared with alendronate 5 mg daily in the prevention of osteoporosis.We compared the efficacy and safety of treatment with alendronate 35 mg once weekly (n = 362) and alendronate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e45c98f4ba7266d01fb63b56318ef563
https://doi.org/10.1016/s0029-7844(03)00008-5
https://doi.org/10.1016/s0029-7844(03)00008-5